These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26239303)

  • 1. In-depth analysis of the critical genes and pathways in colorectal cancer.
    Liu F; Ji F; Ji Y; Jiang Y; Sun X; Lu Y; Zhang L; Han Y; Liu X
    Int J Mol Med; 2015 Oct; 36(4):923-30. PubMed ID: 26239303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key genes in colorectal cancer using random walk with restart.
    Cui X; Shen K; Xie Z; Liu T; Zhang H
    Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
    Peng C; Ma W; Xia W; Zheng W
    Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
    Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
    Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed genes and biological pathways in bladder cancer.
    Tang F; He Z; Lei H; Chen Y; Lu Z; Zeng G; Wang H
    Mol Med Rep; 2018 May; 17(5):6425-6434. PubMed ID: 29532898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key genes and pathways involved in microsatellite instability in colorectal cancer.
    Yu C; Hong H; Zhang S; Zong Y; Ma J; Lu A; Sun J; Zheng M
    Mol Med Rep; 2019 Mar; 19(3):2065-2076. PubMed ID: 30664178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Wu S; Wu F; Jiang Z
    Oncol Rep; 2017 Oct; 38(4):2043-2050. PubMed ID: 28902367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of differentially expressed genes and their upstream regulators in colorectal cancer.
    Liu HY; Zhang CJ
    Cancer Gene Ther; 2017 Jun; 24(6):244-250. PubMed ID: 28409560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genes involved in the four stages of colorectal cancer: Gene expression profiling.
    Shi G; Wang Y; Zhang C; Zhao Z; Sun X; Zhang S; Fan J; Zhou C; Zhang J; Zhang H; Liu J
    Mol Cell Probes; 2018 Feb; 37():39-47. PubMed ID: 29179987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data.
    Xiong Y; You W; Wang R; Peng L; Fu Z
    Biomed Res Int; 2017; 2017():2421459. PubMed ID: 29209625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling.
    Sun LC; Qian HX
    Mol Med Rep; 2018 Jun; 17(6):8260-8268. PubMed ID: 29658574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for genes and subnetworks associated with pancreatic cancer based on the gene expression profile.
    Long J; Liu Z; Wu X; Xu Y; Ge C
    Mol Med Rep; 2016 May; 13(5):3779-86. PubMed ID: 27035224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer.
    Qiu X; Feng JR; Wang F; Chen PF; Chen XX; Zhou R; Chang Y; Liu J; Zhao Q
    Mol Med Rep; 2018 Feb; 17(2):3028-3034. PubMed ID: 29257257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism analysis of colorectal cancer according to the microRNA expression profile.
    Li H; Zhang H; Lu G; Li Q; Gu J; Song Y; Gao S; Ding Y
    Oncol Lett; 2016 Oct; 12(4):2329-2336. PubMed ID: 27698796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of gene expression in rats with spinal cord injury based on microarray data.
    Chen G; Fang X; Yu M
    Mol Med Rep; 2015 Aug; 12(2):2465-72. PubMed ID: 25936407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    Makondi PT; Lee CH; Huang CY; Chu CM; Chang YJ; Wei PL
    PLoS One; 2018; 13(1):e0189582. PubMed ID: 29342159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.